The Utility of Baseline Characteristics and [123I]MIBG Cardiac Adrenergic System Scintigraphy in Qualifying Patients with Post-Infarction Heart Failure for Implantable Cardioverter-Defibrillator (ICD) Placement
Authors:
- Anna TeresińskaATAnna Teresińska
- Aneta Fronczak-JakubczykAFAneta Fronczak-Jakubczyk
- Olgierd WoźniakOWOlgierd Woźniak
- Aleksander MaciągAMAleksander Maciąg
- Jarosław JezierskiJJJarosław Jezierski
- Alicja Cicha-MikołajczykACAlicja Cicha-Mikołajczyk
- Piotr HoffmanPHPiotr Hoffman
- Elżbieta Katarzyna BiernackaEBElżbieta Katarzyna Biernacka
Open Access
- 24 October 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6378
Abstract
Background: Post-infarction heart failure with reduced ejection fraction (HFrEF) patients often face persistent risks of sudden cardiac arrest leading to sudden cardiac death. While implanting a cardioverter-defibrillator (ICD) can enhance prognosis, complications and costs limit its widespread use. Current patient qualification criteria, relying on imperfect parameters, require refinement. The impairment of the cardiac adrenergic system in heart failure is associated with ventricular arrhythmias. The goal of the study was to assess the utility of cardiac adrenergic system scintigraphy in qualifying patients for ICD placement. Methods: In this prospective study of 85 post-infarction HFrEF patients at a single center, clinical assessments, laboratory tests, echocardiography, [123I]MIBG scintigraphy, and ICD implantation were performed. Scintigraphy involved planar chest images and evaluating the heart-to-mediastinum ratio (H/M) and washout rate (WO). SPECT imaging assessed [123I]MIBG uptake in 17 left ventricular segments to calculate the summed difference score (SDS). Results: During a median of 4-year follow-up, 22% of patients experienced appropriate ICD interventions, and 25% of patients died or underwent heart transplantation. The mean values of analyzed parameters did not significantly differ between groups. In the univariate analysis, younger age and moderately impaired left ventricular ejection fraction (LVEF) were correlated with more frequent ICD interventions. In comparison, older age and elevated NT-proBNP levels were associated with death or heart transplantation. Additionally, the univariate analysis identified SDS-15′ as a prognostic factor for death/heart transplant. The multivariate analysis identified predictors for ICD interventions, including younger age, an EF of 30% or greater, and a larger left ventricular end-diastolic diameter. In contrast, older age and an LVEF of less than 25% were significant predictors of death or heart transplantation. Conclusions: Scintigraphic parameters did not effectively predict ICD interventions or death/heart transplantation, though the summed difference score demonstrated potential as a prognostic factor. Younger age with moderately impaired EF correlated with frequent ICD interventions, while in older age, EF < 25% predicted death or transplantation. Further investigation is needed for patients with borderline EF values.Keywords
Funding Information
- National Institute of Cardiology, Warsaw, Poland (2A.26/V/13)
This publication has 29 references indexed in Scilit:
- Quality and utility of [123I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillatorAnnals of Nuclear Medicine, 2021
- Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipientsHeart and Vessels, 2019
- Epidemiology of Sudden Cardiac Death: Global and Regional PerspectivesHeart, Lung and Circulation, 2019
- Cardiac 123 I- m IBG scintigraphy is associated with freedom of appropriate ICD therapy in stable chronic heart failure patientsInternational Journal of Cardiology, 2017
- New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trialsAmerican Heart Journal, 2017
- Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantationNetherlands Heart Journal, 2016
- 123I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantationInternational Journal of Cardiology, 2016
- I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Cardiac Sympathetic Denervation and Ongoing Myocardial Damage for Prognosis in Early Stages of Heart FailureJournal of Cardiac Failure, 2007
- Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathyJACC, 1988